Product Information

VALGANCICLOVIR HCL 50 MG/ML is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.0749 per ML under NDC 70010005140. Its NADAC has been published 188 times since Sep 21, 2022.

FDA first approved this application on Jan 31, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALGANCICLOVIR HCL 50 MG/ML

VALGANCICLOVIR
$1.0749per ML

Strength

50 mg/mL

NDC

70010005140

Classification

Generic

Dosage Form

FOR SOLUTION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VALGANCICLOVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA213306

FDA Approved

1/31/2020

TE Code

AB

On Market Since

7/1/2021

Pharmacological Classes

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
DNA Polymerase Inhibitors
Nucleoside Analog

Price Statistics

The NADAC for VALGANCICLOVIR HCL 50 MG/ML has been published 188 times since Sep 21, 2022, and over the history we have for it it has declined 78.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0749 per ML
All-time high$4.9284 (Sep 13, 2023)
All-time low$0.9898 (Aug 19, 2026)
52-week high$1.4406
52-week low$0.9898
Median price$2.1928
Average price$2.7080
Largest weekly change-30.0% (Apr 17, 2024)
Weeks tracked188
Tracking sinceSep 21, 2022

Price History

1W

+3.9%

1M

+6.9%

3M

+8.6%

6M

-19.0%

1Y

-7.7%

3Y

-78.2%

5Y

N/A

All

-78.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALGANCICLOVIR HCL 50 MG/ML?

The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR HCL 50 MG/ML, manufactured by Granules Pharmaceuticals Inc., is $1.0749 per ML (NDC 70010005140), effective Nov 18, 2026.

How has the price of VALGANCICLOVIR HCL 50 MG/ML changed over time?

Over the history we have for it, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has declined 78.2%. It has been tracked across 188 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR HCL 50 MG/ML?

Since Sep 21, 2022, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has ranged from a low of $0.9898 (Aug 19, 2026) to a high of $4.9284 (Sep 13, 2023), with a median of $2.1928 per ML.

Are there cheaper alternatives to VALGANCICLOVIR HCL 50 MG/ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VALGANCICLOVIR HCL 50 MG/ML in a comparable dosage form, but none are currently priced below it.

Who manufactures VALGANCICLOVIR HCL 50 MG/ML?

VALGANCICLOVIR HCL 50 MG/ML (NDC 70010005140) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.